Biologics, Gene and Cell Therapy Services

Frontage’s Biologics, Gene, and Cell Therapy Operations (BGCT) Unit supports the development of biologics products. We develop complex analytical techniques to support drug substances, drug products, comparability studies, and stability programs.

"*" indicates required fields

Facebook

This field is for validation purposes and should be left unchanged.

First Name*

Last Name*

Company*

State*

Country

Email*

Phone*

Please only hit the submit button once.

I AGREE*

By submitting this form I agree that Frontage may process my data in the manner described in Frontage’s Privacy Policy.

Biologics, Gene and Cell Therapy Services

Resources to Consider

AACR 2023: Evaluation of a 293 gene oncology-focused exome sequencing...

Clonal Neoantigen: Emerging “Mechanism-based” Biomarker of...

WebninarAnalytical Challenges for CMC Development of Cell and Gene...

CAR-T Cell Therapy Services

Gene & Cell Therapy Analytical Services

GMP Analytical Testing in Gene Therapy Products

Gene Therapy Virus Packaging & Quality Control

Cell and Gene Therapy Trends

Gene Therapy

Gene Therapy Podcast with Hugh Davis

Gene Therapy